Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD
20.90
+0.60 (2.96%)
At close: Mar 27, 2026
HKG:2591 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 969.09 | 526.51 | 157.64 |
| 105.43 | 45.15 | 42.55 |
| 130 | 225.19 | 495.13 |
Cash & Short-Term Investments | 1,205 | 796.85 | 695.31 |
| 51.16% | 14.60% | - |
| 5.56 | - | - |
| 137.33 | 7.73 | 1.34 |
| 142.88 | 7.73 | 1.34 |
| 115.94 | 29.04 | 3.45 |
| 15.64 | 5.6 | 257.38 |
| 1,479 | 839.22 | 957.48 |
Property, Plant & Equipment | 35.18 | 13.3 | 54.85 |
| 21.58 | 24.09 | 35.87 |
| 35.27 | 58.19 | 57.17 |
|
| 225.08 | 91.05 | 88.33 |
| 86.87 | 29.95 | 14.51 |
| 150.26 | 9.9 | 1 |
Current Portion of Leases | 3.04 | - | 4.82 |
| - | 1 | - |
Other Current Liabilities | 39.34 | 6.37 | 250.74 |
Total Current Liabilities | 504.58 | 138.26 | 359.4 |
| 12.96 | - | 40.76 |
Other Long-Term Liabilities | 0.07 | 0.07 | 0.07 |
|
| 456.82 | 420.26 | 397.67 |
Additional Paid-In Capital | - | 1,264 | 1,037 |
| - | -1,497 | -1,323 |
Comprehensive Income & Other | 596.58 | 609.28 | 593.24 |
|
Total Liabilities & Equity | 1,571 | 934.8 | 1,105 |
| 166.26 | 9.9 | 46.59 |
| 1,038 | 786.95 | 648.73 |
| 31.94% | 21.31% | - |
| 2.39 | 1.88 | 1.69 |
Filing Date Shares Outstanding | 447.9 | 420.26 | 382.8 |
Total Common Shares Outstanding | 447.91 | 420.26 | 382.8 |
| 974.4 | 700.96 | 598.07 |
| 2.35 | 1.90 | 1.84 |
| 1,032 | 772.38 | 669.26 |
Tangible Book Value Per Share | 2.30 | 1.84 | 1.75 |
| - | 24.56 | 22.43 |
| - | - | 4.45 |
| - | 0.15 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.